Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

CELEXA Drug Profile

« Back to Dashboard
Celexa is a drug marketed by Forest Labs and is included in two NDAs. It is available from three suppliers.

The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-five drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.

Summary for Tradename: CELEXA

Suppliers / Packagers: see list3
Drug Prices: :see details

Pharmacology for Tradename: CELEXA

Clinical Trials for: CELEXA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs
citalopram hydrobromide
TABLET;ORAL020822-001Apr 27, 2000RXNo
Forest Labs
citalopram hydrobromide
TABLET;ORAL020822-004Jul 17, 1998DISCNNo
Forest Labs
citalopram hydrobromide
TABLET;ORAL020822-002Jul 17, 1998RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.